ReviewHeart failure reviews2020

Angiotensin receptor/neprilysin inhibitor-a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings.

Marcin Książczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.